Covid-19 has far-reaching implications, but is first and foremost a global health pandemic. As news of the pandemic evolved, investors tried to assess the impact, looking for defensive stocks to mitigate investment portfolio risks, but also looking for investment opportunities in this catastrophe. Considering the potential demand for hospitalisation, it was reasonable to assume that private hospitals could fare well.

But this has not been the case. Recent results from hospital groups show pressure on occupancies and profitability since mid-March, when groups had to initially prepare for Covid-19 and then saw the subsequent decline in elective surgeries, and in medical and trauma cases since April.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now